Search Results

The Fingertip Pulse Oximeter (DB12) is used for spot-checking of functional arterial oxygen saturation (SpO2) and pulse rate (PR) of adult patients in hospitals, physician's office, clinical settings and home care environment. The Fingertip Pulse Oximeter (DB12) is not intended for continuous monitoring.

Not Found

The provided document is a 510(k) premarket notification approval letter for the Oxicare Fingertip Pulse Oximeter, Model DB12. It confirms the substantial equivalence of the device to legally marketed predicate devices.

However, the document does not contain the detailed information necessary to answer your specific questions regarding acceptance criteria and the study that proves the device meets those criteria.

Specifically, the document does not provide:

1. A table of acceptance criteria and reported device performance.
2. Sample size used for the test set or data provenance. This document only confirms the device's substantial equivalence based on prior (unspecified) testing.
3. Number of experts or their qualifications for ground truth establishment.
4. Adjudication method for the test set.
5. Information on any Multi-Reader Multi-Case (MRMC) comparative effectiveness study. This type of study is more common for diagnostic imaging AI devices, not typically for a simple pulse oximeter.
6. Information on standalone algorithm performance. A pulse oximeter is a physical sensor, not an algorithm in the sense of AI.
7. The type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

The document primarily focuses on the regulatory aspects of the device's clearance, such as its classification, regulation number, and general controls provisions of the Act. While it implies that the device has undergone testing to demonstrate its performance for "spot-checking of functional arterial oxygen saturation (SpO2) and pulse rate (PR)", the details of how that performance was assessed against specific criteria are not included in this FDA letter. Such details would typically be found in the manufacturer's 510(k) submission, which is not fully provided here.

Ask a specific question about this device

The OxiCare Fingertip Pulse Oximeter, model DB11 is indicated for spot-checking of functional arterial oxygen saturation (SpO2) and pulse rate (PR) of adult and pediatric patients in hospitals, physician's office, clinical settings and home care environment. The OxiCare Fingertip Pulse Oximeter, model DB11 is not intended for continuous monitoring.

Not Found

The provided document is a 510(k) premarket notification letter for the Oxicare Fingertip Pulse Oximeter, Model DB11. It does not contain the detailed acceptance criteria for performance, nor does it describe specific studies that prove the device meets such criteria. This letter primarily confirms the FDA's determination of substantial equivalence to a predicate device.

Therefore, I cannot extract the requested information from this document. The document confirms market clearance but does not elaborate on the technical performance data that led to this clearance.

Ask a specific question about this device